Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate enGene Holdings Inc. before investing.

In this article, we go over a few key elements for understanding enGene Holdings Inc.’s stock price such as:

• enGene Holdings Inc.’s current stock price and volume
• Why enGene Holdings Inc.’s stock price changed recently
• Upgrades and downgrades for ENGN from analysts
• ENGN’s stock price momentum as measured by its relative strength

About enGene Holdings Inc. (ENGN)

Before we jump into enGene Holdings Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.

Want to learn more about enGene Holdings Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about enGene Holdings Inc..

enGene Holdings Inc.’s Stock Price as of Market Close

As of November 28, 2025, 1:00 PM, CST, enGene Holdings Inc.’s stock price was $8.070.

enGene Holdings Inc. is down 2.18% from its previous closing price of $8.250.

During the last market session, enGene Holdings Inc.’s stock traded between $7.920 and $8.360. Currently, there are approximately 51.10 million shares outstanding for enGene Holdings Inc..

enGene Holdings Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

enGene Holdings Inc. Stock Price History

enGene Holdings Inc.’s (ENGN) price is currently up 11.93% so far this month.

During the month of November, enGene Holdings Inc.’s stock price has reached a high of $11.140 and a low of $5.720.

Over the last year, enGene Holdings Inc. has hit prices as high as $11.140 and as low as $2.650. Year to date, enGene Holdings Inc.’s stock is up 21.35%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused enGene Holdings Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 26, 2025, there was 1 analyst who downgraded enGene Holdings Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate enGene Holdings Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on enGene Holdings Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about enGene Holdings Inc. (ENGN) by visiting AAII Stock Evaluator.

Relative Price Strength of enGene Holdings Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 26, 2025, enGene Holdings Inc. has a weighted four-quarter relative price strength of 17.23%, which translates to a Momentum Score of 90 and is considered to be Very Strong.

Want to learn more about how enGene Holdings Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

enGene Holdings Inc. Stock Price: Bottom Line

As of November 28, 2025, enGene Holdings Inc.’s stock price is $8.070, which is down 2.18% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like enGene Holdings Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.